Nomogram for hospital-acquired venous thromboembolism among patients with cardiovascular diseases

被引:2
|
作者
Luo, Qin [1 ]
Li, Xin [1 ]
Zhao, Zhihui [1 ]
Zhao, Qing [1 ]
Liu, Zhihong [1 ]
Yang, Weixian [2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Ctr Pulm Vasc Dis, Fuwai Hosp, Natl Ctr Cardiovasc Dis, 167 Beilishi Rd, Beijing 100037, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiol, Beijing, Peoples R China
关键词
Nomogram; Venous thromboembolism; Cardiovascular diseases; Padua score; Prediction model; Hospital-acquired; MEDICAL INPATIENTS;
D O I
10.1186/s12959-024-00584-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundIdentifying venous thromboembolism (VTE) is challenging for patients with cardiovascular diseases due to similar clinical presentation. Most hospital-acquired VTE events are preventable, whereas the implementation of VTE prophylaxis in clinical practice is far from sufficient. There is a lack of hospital-acquired VTE prediction models tailored specifically designed for patients with cardiovascular diseases. We aimed to develop a nomogram predicting hospital-acquired VTE specifically for patients with cardiovascular diseases.Material and methodsConsecutive patients with cardiovascular diseases admitted to internal medicine of Fuwai hospital between September 2020 and August 2021 were included. Univariable and multivariable logistic regression were applied to identify risk factors of hospital-acquired VTE. A nomogram was constructed according to multivariable logistic regression, and internally validated by bootstrapping.ResultsA total of 27,235 patients were included. During a median hospitalization of four days, 154 (0.57%) patients developed hospital-acquired VTE. Multivariable logistic regression identified that female sex, age, infection, pulmonary hypertension, obstructive sleep apnea, acute coronary syndrome, cardiomyopathy, heart failure, immobility, central venous catheter, intra-aortic balloon pump and anticoagulation were independently associated with hospital-acquired VTE. The nomogram was constructed with high accuracy in both the training set and validation (concordance index 0.865 in the training set, and 0.864 in validation), which was further confirmed in calibration. Compared to Padua model, the Fuwai model demonstrated significantly better discrimination ability (area under curve 0.865 vs. 0.786, net reclassification index 0.052, 95% confidence interval 0.012-0.091, P = 0.009; integrated discrimination index 0.020, 95% confidence interval 0.001-0.039, P = 0.051).ConclusionThe incidence of hospital-acquired VTE in patients with cardiovascular diseases is relatively low. The nomogram exhibits high accuracy in predicting hospital-acquired VTE in patients with cardiovascular diseases.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] IDENTIFYING TIME INTERVAL FEATURES PREDICTIVE OF HOSPITAL-ACQUIRED VENOUS THROMBOEMBOLISM
    Pellathy, Tiffany
    Chen, Lujie
    Clermont, Gilles
    Dubrawski, Artur
    Pinsky, Michael
    Hravnak, Marilyn
    CRITICAL CARE MEDICINE, 2019, 47
  • [22] Prevention of Hospital-Acquired venous Thromboembolism in Children: A Review of Published Guidelines
    Faustino, E. Vincent S.
    Raffini, Leslie J.
    FRONTIERS IN PEDIATRICS, 2017, 5
  • [23] PRAGMATIC INTERVENTIONS TO PREVENT HOSPITAL-ACQUIRED VENOUS THROMBOEMBOLISM EVENTS.
    Kutzler, Deidre
    Karasek, Nicole
    ONCOLOGY NURSING FORUM, 2017, 44 (02)
  • [24] Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients
    Blondon, Marc
    Spirk, David
    Kucher, Nils
    Aujesky, Drahomir
    Hayoz, Daniel
    Beer, Jurg H.
    Husmann, Marc
    Frauchiger, Beat
    Korte, Wolfgang
    Wuillemin, Walter A.
    Bounameaux, Henri
    Righini, Marc
    Nendaz, Mathieu
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (01) : 82 - 89
  • [25] Prevalence of Risk Factors for Hospital-Acquired Venous Thromboembolism in Neurosurgery and Orthopedic Spine Surgery Patients
    Fischer, Charla R.
    Wang, Erik
    Steinmetz, Leah
    Vasquez-Montes, Dennis
    Buckland, Aaron
    Bendo, John
    Frempong-Boadu, Anthony
    Errico, Thomas
    INTERNATIONAL JOURNAL OF SPINE SURGERY, 2020, 14 (01): : 79 - 86
  • [26] Risk Factors for Hospital-Acquired Venous Thromboembolism in Children: Findings from the Children's Hospital-Acquired Thrombosis (CHAT) Registry
    Branchford, Brian R.
    Jaffray, Julie
    Croteau, Stacy E.
    Silvey, Michael
    Bakeer, Nihal
    Cooper, James D.
    Fargo, John H.
    Ji, Lingyun
    Sposto, Richard
    Malvar, Jemily
    Krava, Emily
    Stillings, Amy
    Goldenberg, Neil A.
    Young, Guy
    Mahajerin, Arash
    BLOOD, 2018, 132
  • [27] HOSPITAL-ACQUIRED VENOUS THROMBOEMBOLISM AND INVASIVE VENTILATION: A REPORT FROM THE CHAT CONSORTIUM
    Sochet, Anthony
    Jaffray, Julie
    Branchford, Brian
    Havlicek, Elizabeth
    Mosha, Maua
    Goldenberg, Neil
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 23 - 23
  • [28] Predictive Value of the Present-On-Admission Indicator for Hospital-acquired Venous Thromboembolism
    Khanna, Raman R.
    Kim, Sharon B.
    Jenkins, Ian
    El-Kareh, Robert
    Afsarmanesh, Nasim
    Amin, Alpesh
    Sand, Heather
    Auerbach, Andrew
    Chia, Catherine Y.
    Maynard, Gregory
    Romano, Patrick S.
    White, Richard H.
    MEDICAL CARE, 2015, 53 (04) : E31 - E36
  • [29] ROOT CAUSE ANALYSIS OF HOSPITAL-ACQUIRED VENOUS THROMBOEMBOLISM: A QUALITY IMPROVEMENT INITIATIVE
    Valenzuela, Valentine
    Varma, Gulzar
    Bartle, William
    Brown, Paula
    Diamantouros, Artemis
    Geerts, William
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E75 - E75
  • [30] Association of pharmacologic thromboprophylaxis with clinically relevant bleeding and hospital-acquired anemia in medical inpatients: the risk stratification for hospital-acquired venous thromboembolism in medical patients study
    Choffat, Damien
    Rossel, Jean-Benoit
    Aujesky, Drahomir
    Vollenweider, Peter
    Baumgartner, Christine
    Mean, Marie
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (03) : 765 - 774